Menu

Topics

Connect

Comments

Comments closed.

Due to the sensitive and/or legal subject matter of some of the content on globalnews.ca, we reserve the ability to disable comments from time to time.

Please see our Commenting Policy for more.

Racing to develop a treatment for COVID-19

The race is one to develop a vaccine for COVID-19. At best it could take up to 18 months, but a Vancouver biotech company is working on a solution that may be available sooner. AbCellera CEO Carl Hansen explains.

Advertisement

More Videos

Advertisement

You are viewing an Accelerated Mobile Webpage.

View Original Article